---
id: ITE-2022-178
type: ITE
year: 2022
number: 178
created: 2025-08-08 07:54:57.713272
tags:
- ITE
- question
- ITE-2022
answer: C
topic: null
related_articles:
- title: Finerenone (Kerendia) for the Treatment of Chronic Kidney Disease in Patients
    With Type 2 Diabetes Mellitus.
  path: 2023/2023-09-finerenone-kerendia-for-the-treatment-of-chronic-kidney-dise.md
  similarity: 0.857
  link: '[[2023/2023-09-finerenone-kerendia-for-the-treatment-of-chronic-kidney-dise|Finerenone
    (Kerendia) for the Treatment of Chronic Kidney Disease in Patients With Type 2
    Diabetes Mellitus.]]'
- title: Interventions for Fatigue in Patients With Kidney Failure Who Are Receiving
    Dialysis.
  path: 2025/2025-02-interventions-for-fatigue-in-patients-with-kidney-failure-wh.md
  similarity: 0.571
  link: '[[2025/2025-02-interventions-for-fatigue-in-patients-with-kidney-failure-wh|Interventions
    for Fatigue in Patients With Kidney Failure Who Are Receiving Dialysis.]]'
- title: Updates to Management of Adults With Chronic Kidney Disease.
  path: 2025/2025-03-updates-to-management-of-adults-with-chronic-kidney-disease.md
  similarity: 0.571
  link: '[[2025/2025-03-updates-to-management-of-adults-with-chronic-kidney-disease|Updates
    to Management of Adults With Chronic Kidney Disease.]]'
- title: 2023-05-index
  path: 2023/2023-05-index.md
  similarity: 0.571
  link: '[[2023/2023-05-index|2023-05-index]]'
- title: 'Should Metformin Continue as First-Line Pharmacotherapy for Patients With
    Type 2 Diabetes? Yes: Metformin Is Still the Best Choice.'
  path: 2024/2024-03-should-metformin-continue-as-first-line-pharmacotherapy-for.md
  similarity: 0.571
  link: '[[2024/2024-03-should-metformin-continue-as-first-line-pharmacotherapy-for|Should
    Metformin Continue as First-Line Pharmacotherapy for Patients With Type 2 Diabetes?
    Yes: Metformin Is Still the Best Choice.]]'
topics:
- Acute Kidney Injury
- Nephrology
- Neurology
- Psychiatry
related_articles_2023_2025:
- title: afp clinical answers
  path: 2023/12/2023-12-afp-clinical-answers.md
  similarity: 0.415
  link: '[[2023/12/2023-12-afp-clinical-answers|afp clinical answers]]'
- title: ischemic stroke
  path: 2023/07/2023-07-ischemic-stroke.md
  similarity: 0.317
  link: '[[2023/07/2023-07-ischemic-stroke|ischemic stroke]]'
- title: afp clinical answers
  path: 2024/10/2024-10-afp-clinical-answers.md
  similarity: 0.315
  link: '[[2024/10/2024-10-afp-clinical-answers|afp clinical answers]]'
- title: practice guidelines headache pregnancy ureastfeeding
  path: 2023/07/2023-07-practice-guidelines-headache-pregnancy-breastfeeding.md
  similarity: 0.312
  link: '[[2023/07/2023-07-practice-guidelines-headache-pregnancy-breastfeeding|practice
    guidelines headache pregnancy ureastfeeding]]'
- title: afp clinical answers
  path: 2024/06/2024-06-afp-clinical-answers.md
  similarity: 0.309
  link: '[[2024/06/2024-06-afp-clinical-answers|afp clinical answers]]'
last_updated: '2025-08-10T20:25:51.926689'
---

# Question ITE-2022-178

the hospital with acute kidney injury due to dehydration, along with generalized weakness and ambulatory dysfunction. Prior to his hospitalization he lived independently with part-time caregiver assistance. Over the next 2 days his renal function improves, although physical and occupational therapy evaluations reveal significant deficits in his activities of daily living. The decision is made to transfer him to a skilled nursing facility. In planning for his discharge, you discuss completion of a Physician Orders for Life-Sustaining Treatment (POLST) form with the patient and his daughter, who says that her father already has an advance directive. She asks you what distinguishes a POLST form from other advanced care planning documents. You explain to her that, as opposed to an advance directive, a POLST form

## Options

**A.** does not require a signature from a treating physician

**B.** is required for patients with a terminal illness in hospice care

**C.** provides specific orders for emergency medical services

**D.** should be completed for all patients during an annual Medicare wellness visit

**E.** supersedes the expressed wishes of a patient who can communicate

## Answer

**C**

## Explanation

An organization that is now known as National POLST began as an advisory panel and task force to
improve consistency in honoring the wishes of patients with serious illness or frailty regarding end-of-life
care. POLST, originally an acronym for Physician Orders for Life-Sustaining Treatment, varies in name
at the state level, although at the national level POLST is defined as a portable medical order. POLST
forms differ from other legal advanced care planning documents such as advance directives and living
wills, although the processes can work together.
70

--- Page 72 ---
The primary (see [[Articles/2023/2023-05-diabetes-management-primary-care.md|Diabetes Management in Primary Care: Evidence-Based Approaches]]) purpose of a POLST form is to provide specific medical orders in the event that a patient is
unable to communicate. Legal advanced care planning documents, in contrast, express general treatment
wishes and identify a health care proxy for surrogate decision-making but do not provide specific orders
for care. POLST forms are completed by a treating physician and signed by the patient or surrogate and
the ...



## Related Articles

- [[Articles/2023/2023-05-diabetes-management-primary-care.md|Diabetes Management in Primary Care: Evidence-Based Approaches]]

## References

*[To be added from answer key]*
